Once-weekly semaglutide versus placebo in adults with increased fracture risk: a randomised, double-blinded, two-centre, phase 2 trial

Morten S. Hansen*, Eva M. Wölfel, Shakespeare Jeromdesella, Jens Jakob K. Møller, Charlotte Ejersted, Niklas R. Jørgensen, Richard Eastell, Stinus G. Hansen, Morten Frost

*Corresponding author for this work

Research output: Contribution to journal › Journal article › Research › peer-review

34 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Once-weekly semaglutide versus placebo in adults with increased fracture risk: a randomised, double-blinded, two-centre, phase 2 trial'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science